Back to search

Article

Upregulated ONECUT2 impeded the efficacy of 5-FU treatment to relapsed patients and might be an emerging indicator of chemotherapy in gastric cancer

2022-05-10

Abstract excerpt

<h4>Background: </h4> Chemotherapeutic resistance is a main obstacle for prolonging the lifetime of gastric cancer (GC) patients, so new emerging solutions still remain to be investigated. We aim to identify an effective target, ONECTU2, for chemotherapy of GC patient, particularly relapsed patients. <h4>Methods: </h4>: STAD patients matched with clinical features and transcriptome sequencing data from TCGA were u...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
68e5b258-ac1a-5d4a-aeb0-8716e493a35f
DOI
10.21203/rs.3.rs-1497914/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Upregulated ONECUT2 impeded the efficacy of 5-FU treatment to relapsed patients and might be an emerging indicator of chemotherapy in gastric cancerDOI 10.21203/rs.3.rs-1497914/v2
Select a neighboring publication to make it the new centre.